Tonix Pharmaceuticals to Present an Analysis of Phase 3 Data on TONMYA® at the IASP 2026 World Congress on Pain
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| TONIX PHARM HLDG (NASDAQ: TNXP) | Delayed: 5.13 -0.3 (5.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.43 | 52 Week High | $7.95 | |||
| Open | $5.37 | 52 Week Low | $0.40 | |||
| Day High | $5.46 | P/E | N/A | |||
| Day Low | $5.05 | EPS | $-5.33 | |||
| Volume | 899,279 | |||||
